Dr. Hanes’ research interests include the pharmacokinetic and pharmacodynamic evaluation of antimicrobials in the intensive care unit setting.  Specific areas of interest are clinical outcomes associated with inadequate empiric antibiotic therapy and the utilization of biomarkers as surrogate markers of pharmacodynamic response and clinical outcomes.